Revolution Medicines, Inc. SEC filings RVMDW

Revolution Medicines, Inc. has 862 filings in SEC EDGAR's recent list, going back to Dec 21, 2016. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Revolution Medicines, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2026 —
4 Insider transaction Oct 28, 2026 Oct 26, 2026
8-K Current report
New debt, Other events
Oct 13, 2026 Oct 8, 2026
4 Insider transaction Oct 1, 2026 Sep 29, 2026
4 Insider transaction Sep 29, 2026 Sep 25, 2026
144 Notice of proposed sale Sep 29, 2026 —
4 Insider transaction Sep 28, 2026 Sep 24, 2026
144 Notice of proposed sale Sep 25, 2026 —
4 Insider transaction Sep 24, 2026 Sep 22, 2026
144 Notice of proposed sale Sep 24, 2026 —
4 Insider transaction Sep 22, 2026 Sep 18, 2026
144 Notice of proposed sale Sep 22, 2026 —
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
144 Notice of proposed sale Sep 18, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
144 Notice of proposed sale Sep 11, 2026 —
4 Insider transaction Sep 10, 2026 Sep 8, 2026
144 Notice of proposed sale Sep 10, 2026 —
4 Insider transaction Sep 2, 2026 Aug 31, 2026
8-K Current report
Material agreement, New debt
Sep 1, 2026 Aug 27, 2026
144 Notice of proposed sale Aug 31, 2026 —
8-K Current report
Other events
Aug 26, 2026 Aug 26, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2026 —
4 Insider transaction Jul 1, 2026 Jun 29, 2026
144 Notice of proposed sale Jun 29, 2026 —
4 Insider transaction Jun 26, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 24, 2026 —
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 15, 2026 Jun 11, 2026
144 Notice of proposed sale Jun 11, 2026 —
4 Insider transaction May 28, 2026 May 26, 2026
144 Notice of proposed sale May 26, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
4 Insider transaction Apr 29, 2026 Apr 27, 2026
DEFA14A Additional proxy material Apr 28, 2026 —
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 27, 2026 Jun 18, 2026
144 Notice of proposed sale Apr 27, 2026 —
4 Insider transaction Apr 17, 2026 Apr 15, 2026
8-K Current report
Material agreement, New debt, Other events
Apr 17, 2026 Apr 14, 2026
8-K Current report
Other events
Apr 16, 2026 Apr 14, 2026
424B5 Prospectus supplement Apr 15, 2026 —
424B5 Prospectus supplement Apr 15, 2026 —
144 Notice of proposed sale Apr 15, 2026 —
305B2 Filing Apr 15, 2026 —
FWP Free writing prospectus Apr 15, 2026 —
424B5 Prospectus supplement Apr 13, 2026 —
424B5 Prospectus supplement Apr 13, 2026 —
8-K Current report
Other events
Apr 13, 2026 Apr 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 26, 2026 Mar 25, 2026
144 Notice of proposed sale Mar 26, 2026 —
3 Initial insider ownership Mar 26, 2026 Mar 20, 2026
3 Initial insider ownership Mar 26, 2026 Mar 20, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
144 Notice of proposed sale Mar 19, 2026 —
144 Notice of proposed sale Mar 13, 2026 —
144 Notice of proposed sale Mar 13, 2026 —
144 Notice of proposed sale Mar 13, 2026 —
144 Notice of proposed sale Mar 13, 2026 —
144 Notice of proposed sale Mar 13, 2026 —
144 Notice of proposed sale Mar 13, 2026 —
144 Notice of proposed sale Mar 13, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
424B5 Prospectus supplement Feb 25, 2026 —
S-8 Employee stock plan registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 10, 2026 Feb 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 9, 2026 —
4 Insider transaction Jan 23, 2026 Jan 21, 2026
144 Notice of proposed sale Jan 21, 2026 —
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
144 Notice of proposed sale Dec 12, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
4 Insider transaction Nov 26, 2025 Nov 25, 2025
4 Insider transaction Nov 26, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
144 Notice of proposed sale Nov 25, 2025 —
144 Notice of proposed sale Nov 25, 2025 —
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
4 Insider transaction Nov 14, 2025 Nov 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 13, 2025 Nov 11, 2025
4 Insider transaction Nov 12, 2025 Nov 7, 2025
144 Notice of proposed sale Nov 12, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
144 Notice of proposed sale Nov 7, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 5, 2025 —
4 Insider transaction Oct 20, 2025 Oct 17, 2025
4 Insider transaction Oct 20, 2025 Oct 16, 2025
144 Notice of proposed sale Oct 17, 2025 —
144 Notice of proposed sale Oct 17, 2025 —
8-K Current report
Other events
Oct 17, 2025 Oct 16, 2025
144 Notice of proposed sale Oct 16, 2025 —
4 Insider transaction Oct 15, 2025 Oct 13, 2025
4 Insider transaction Sep 26, 2025 Sep 24, 2025
144 Notice of proposed sale Sep 24, 2025 —
4 Insider transaction Sep 18, 2025 Sep 16, 2025
4 Insider transaction Sep 18, 2025 Sep 16, 2025
4 Insider transaction Sep 18, 2025 Sep 16, 2025
4 Insider transaction Sep 18, 2025 Sep 16, 2025
4 Insider transaction Sep 18, 2025 Sep 16, 2025
4 Insider transaction Sep 18, 2025 Sep 16, 2025
144 Notice of proposed sale Sep 15, 2025 —
144 Notice of proposed sale Sep 15, 2025 —
144 Notice of proposed sale Sep 15, 2025 —
144 Notice of proposed sale Sep 15, 2025 —
144 Notice of proposed sale Sep 15, 2025 —
144 Notice of proposed sale Sep 15, 2025 —
4 Insider transaction Sep 15, 2025 Sep 11, 2025
144 Notice of proposed sale Sep 11, 2025 —
8-K Current report
Other events
Sep 10, 2025 Sep 10, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 2, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
RVMD (Nasdaq), RVMDW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Redwood City, CA
SEC filer status
Large accelerated filer
SEC CIK
1628171

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.